These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 18500519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.
    Harner KC, Jackson LW, Drabick JJ.
    Rheumatology (Oxford); 2004 Oct; 43(10):1309-10. PubMed ID: 15448217
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.
    Kalpadakis C, Pangalis GA, Sachanas S, Rontogianni D, Korkolopoulou P, Milionis V, Vassilakopoulos TP, Papadaki HA, Angelopoulou MK.
    Leuk Lymphoma; 2016 Nov; 57(11):2705-8. PubMed ID: 27082039
    [No Abstract] [Full Text] [Related]

  • 9. Severe Protein-Losing Enteropathy Due to an Indolent Splenic Lymphoma: Case Report and Review of the Literature.
    Naymagon L, Ward S, Naymagon S, Navada S.
    Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):e165-e168. PubMed ID: 30685184
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy].
    Fujita T, Asagoe K, Sakoda H.
    Rinsho Ketsueki; 2003 Apr; 44(4):249-53. PubMed ID: 12784658
    [Abstract] [Full Text] [Related]

  • 15. [Pulmonary MALT lymphoma with macroglobulinemia].
    Takasaki H, Takabayashi M, Yamaji S, Koharazawa H, Fujimaki K, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2005 Feb; 46(2):144-6. PubMed ID: 16447709
    [Abstract] [Full Text] [Related]

  • 16. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ, Ali S.
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.
    Manner H, Jung B, Tonassi L, Hackenberg U, Plum N, Josten KM, Kirchmaier CM, Frickhofen N.
    Am J Med Sci; 2008 May; 335(5):394-7. PubMed ID: 18480659
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.